Cambrex Corp., a manufacturer of small molecule active pharmaceutical ingredients (APIs), and finished dosage forms, is investing $1 million at its High Point, NC site to add 1,300 sq.-ft. of analytical lab space and nine chemical research and development scientists, as well as six analytical research and development scientists. This investment follows the new $3.2 million, 11,000 sq.-ft. analytical lab, completed in April 2018.   The expansion will include the installation of an additional 10...